GTC Biotherapeutics (fka GTCB)

[vinmantoo]

Biopearl,

As usual JohnBits is speaking out his butt with no real knowledge. GTCB's transgenic methodology is being used to make proteins that cannot be made in significant quanties or economically by traditional methods, which is the shift in GTCB's strategy to plasma proteins and BCE by pharmathene. The issue of MAbs is distinct, and is where GTCB ran into real resisitance.

I am still amused by JohBits saying it might be better to know less about a company and its science when making investment decisions. That is all you need to know about him and his opinions. He doesn't know much but feels the urgent need to continually keep tell us about GTCB.